Literature DB >> 34342761

The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.

Shu-Chun Lin1,2,3, Chung-Ji Liu2,4, Si-Hua Ji1, Wan-Wen Hung1, Ying-Chieh Liu1, Sih-Rou Chang1, Hsi-Feng Tu1,2,5, Kuo-Wei Chang6,7,8.   

Abstract

OBJECTIVES: Oncogenic miRNAs upregulated in OSCC play a range of versatile roles in oral carcinogenesis. Oral potentially malignant disorders (OPMDs) are the antecedent lesions to oral squamous carcinoma (OSCC) and they require a definitive diagnosis and early intervention. This study hypothesizes the presence of aberrant oncogenic miRNA expression in swabbed oral lesions.
MATERIALS AND METHODS: The expression of miR-21, miR-31, miR-134, miR-146a, and miR-211 in swabbed samples from 36 dysplastic or hyperplastic OPMDs and 10 OSCCs, relative to respective normal mucosa within the same patient, is analyzed with qRT-PCR to develop a diagnosis.
RESULTS: Upregulation of all tested miRNAs in OPMD and OSCC samples comparing to controls is found to have occurred. Receiver operating characteristics curve analysis shows that miR-31 gives the best diagnostic accuracy of 0.91 when differentiating OPMD/OSCC from controls. An analysis of miR-134 and miR-211 expression allows the discrimination of the dysplastic state associated with OPMD, while the use of expression of the combined miRNAs further improves the analytical performances when identifying the dysplastic state. The concordant upregulation of miR-21, miR-31, and miR-146a is found to occur during an early stage of OSCC carcinogenesis.
CONCLUSION: This study demonstrates the upregulation of multiple oncogenic miRNAs in swabbed OPMD and OSCC samples. miRNA expression in swabbed collectives enables the differentiation between normal mucosa and OPMD/OSCC, independent of their histopathological severity. CLINICAL RELEVANCE: This conventional and convenient sampling tool, when coupled with an assessment of miR-31 expression, would seem to be an adjuvant approach to the diagnosis of OPMD and OSCC.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Marker; Oral carcinoma; Premalignancy; Swab; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34342761     DOI: 10.1007/s00784-021-04108-y

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  39 in total

1.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

Authors:  Chung-Ji Liu; Meng-Miao Tsai; Pei-Shih Hung; Shou-Yen Kao; Tsung-Yun Liu; Kou-Juey Wu; Shih-Hwa Chiou; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

2.  Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.

Authors:  Lihong He; Fan Ping; Zhaona Fan; Chi Zhang; Miao Deng; Bin Cheng; Juan Xia
Journal:  Biomed Pharmacother       Date:  2019-11-05       Impact factor: 6.529

3.  Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.

Authors:  Angela B Y Hui; Michelle Lenarduzzi; Tiffaney Krushel; Levi Waldron; Melania Pintilie; Wei Shi; Bayardo Perez-Ordonez; Igor Jurisica; Brian O'Sullivan; John Waldron; Pat Gullane; Bernard Cummings; Fei-Fei Liu
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

Review 4.  Early Diagnosis of Oral Squamous Cell Carcinoma by Salivary microRNAs.

Authors:  Raluca Dumache
Journal:  Clin Lab       Date:  2017-11-01       Impact factor: 1.138

5.  miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.

Authors:  Chung-Ji Liu; Wilma Grace Shen; Shih-Yuan Peng; Hui-Wen Cheng; Shou-Yen Kao; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Int J Cancer       Date:  2013-10-08       Impact factor: 7.396

6.  microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection.

Authors:  Qianting He; Zujian Chen; Robert J Cabay; Leitao Zhang; Xianghong Luan; Dan Chen; Tianwei Yu; Anxun Wang; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

7.  Paper-Based Strip for Ultrasensitive Detection of OSCC-Associated Salivary MicroRNA via CRISPR/Cas12a Coupling with IS-Primer Amplification Reaction.

Authors:  Minghui Chen; Ran Luo; Shenghui Li; Hengxuan Li; Yi Qin; Dianming Zhou; Hao Liu; Xiaoqun Gong; Jin Chang
Journal:  Anal Chem       Date:  2020-09-14       Impact factor: 6.986

8.  MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.

Authors:  Yi-Fen Chen; Cheng-Chieh Yang; Shou-Yen Kao; Chung-Ji Liu; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2016-05-24       Impact factor: 12.701

9.  Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers.

Authors:  Scott Langevin; Damaris Kuhnell; Tess Parry; Jacek Biesiada; Shouxiong Huang; Trisha Wise-Draper; Keith Casper; Xiang Zhang; Mario Medvedovic; Susan Kasper
Journal:  Oncotarget       Date:  2017-07-27

10.  miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.

Authors:  Pei-Shi Hung; Chung-Ji Liu; Chung-Shan Chou; Shou-Yen Kao; Cheng-Chieh Yang; Kuo-Wei Chang; Ting-Hui Chiu; Shu-Chun Lin
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more
  1 in total

1.  Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma.

Authors:  Hsi-Feng Tu; Chung-Ji Liu; Wan-Wen Hung; Tzong-Ming Shieh
Journal:  J Dent Sci       Date:  2021-11-27       Impact factor: 3.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.